期刊文献+

沙眼衣原体真核表达质粒pcDNA4/CT703的构建及其表达

Construction and Expression of Eukaryotic Expression Plasmid pcDNA4/CT703 of Chlamydia trachomatis
下载PDF
导出
摘要 目的:构建含沙眼衣原体(Chlamydia trachomatis,Ct)基因CT703的真核重组表达质粒pcDNA4/CT703,并检测其在HeLa细胞中的表达。方法:利用RT-PCR扩增CT703基因,然后将其亚克隆到真核表达载体pcDNA4,PCR、双酶切和测序检测重组质粒。将正确的重组质粒瞬时转染HeLa细胞,免疫荧光和WesternBlot实验检测重组质粒目的蛋白表达。结果:经PCR、双酶切和测序鉴定后,成功构建了真核重组表达质粒pcDNA4/CT703,将其转染HeLa细胞后,免疫荧光和Western Blot实验能检测到目的蛋白的表达。结论:成功构建了重组质粒pcDNA4/CT703,并能在HeLa细胞中表达,为进一步研究CT703的功能奠定了基础。 Objective:To construct a recombinant eukaryotic expression plasmid of pcDNA4/CT703 containing CT703 gene of Chlamydia trachomatis and study its expression in HeLa cells. Methods:CTT03 gene was obtained by RT-PCR and subcloned into the eukaryotic expression vectors pcDNA4, the recombinant plasmid was detected by PCR,restriction enzyme digestion and sequence analysis, pcDNA4/CTT03 was transiently transfected into HeLa cells, Immunofluorescence and Western Blot assay was used to detect the expression of recombinant proteins. Results : Enkaryotic expression plasmid pcDNA4/CTT03 had been constnicted successfully, which was demonstrated by PCR, restriction enzyme digestion and sequence analysis; after transfected into HeLa cells, the expression of CT703 protein was demonstrated by Immunofluorescence and Western Blot assay. Conclusion:The cukaryotic expression plasmid pcDNA4/CTT03 had been constructed successfully and could express CT703 protein in HeLa cells, which laid the foundation for further study.
出处 《激光生物学报》 CAS CSCD 2010年第6期809-812,797,共5页 Acta Laser Biology Sinica
基金 国家自然科学基金项目(30600534)
关键词 沙眼衣原体 重组质粒 基因转染 蛋白表达 Chlamydia trachomatis recombinant plasmid gent transfection protein expression
  • 相关文献

参考文献13

  • 1HANNU T,INMAN R,GRANFORS K,et al.Best Reactive Arthritis or Infection Arthritis[J].Pract Res Clin Rheumatol,2006,20(3):419-433.
  • 2MICHAEL C J,ELKE R,MICHAEL M,et al.Cytokine Profile in Serum and Synovid Fluid of Arthritis Patients with Chlamydia Trachomatis Infection[J].Rheumatol Int,2005,25(1):37-41.
  • 3PINKERTON S D,LAYDE P M.Using Sexually Transmitted Disease Incidence as a Surrogate Marker for HIV Incidence in Prevention Trials:a Modeling Study[J].Sex Transm Dis,2002,29(5):298-307.
  • 4WALLIN K L,WIKLUND F,LUOSTARIINEN T,et al.A Population-based Prospective Study of Chlamydia Trachomatis Infection and Cervical Carcinoma[J].Inter J Cancer,2002,101(4):371-374.
  • 5LUOSTARINE T,STATTIN P,SAIKKU P,et al.Chlamydial Antibody and Risk of Prostate Cancer[J].Cancer Epidenmiol Biomarkers Prev,2005,14(2):385-389.
  • 6HACKSTADT T.The Diverse Habitats of Obligate Intracellular Parasites[J].Current Opinion in Microbiology,1998,1(1):82-87.
  • 7HACKSTADE T,FISCHER E R,SCIDMORE M A,et al.Origins and Functions of the Chlamydial Inclusion[J].Trends Microbiol,1997 5(7):288-293.
  • 8ZHONG G,FAN P,JI H,et al.Identification of a Chlamydial Proteas Immunofluorescence and Western Blot Assay e-like Activity Factor Responsible for the Degradation of Host Transcription Factor[J].J Exp Med,2001,193(8):935-942.
  • 9魏秀青,程文,严杰,梅冰,霍治,余平.沙眼衣原体感染Hela229细胞诱导SOCS-1,3的表达[J].中南大学学报(医学版),2004,29(6):639-642. 被引量:4
  • 10SU H,MCCLARTY G,DONG F,et al.Activation of Raf/MEK/ERK/cPLA2 Signaling Pathway is Essential for Chlamydia Acquisition of Host Glycerophomatis[J].J Biol Chem,2004,279(10):9409-9416.

二级参考文献15

  • 1Barkai U, Prigent-Tessier A, Tessier C, et al. Involvement of SOCS-1, the suppressor of cytokine signaling, in the prevention of prolactin-responsive gene expression in decidual cells [ J ]. Mol Endocrinol, 2000, 14(4) :554-563.
  • 2Mahboubi K, Kirkiles-Smith NC, Karras J, et al. Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3 [J]. J Biol Chem, 2003, 278 (27) :25014-25023.
  • 3Pantoja LG, Miller RD, Ramirez JA, et al. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity [J]. Infect Immun, 2000,68( 11 ) :6478-6481.
  • 4Ramsey KH, Sigar IM, Rana SV,et al. Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals [J]. Infect Immun ,2001,69 ( 12 ) :7374-7379.
  • 5Freidank HM, Billing H, Wiedmann-Al-Ahmad M. Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis [ J ].J Med Microbiol, 2001, 50(3) :223-227.
  • 6Al-Younes HM, Rudel T, Brinkmann V. Low iron availability modulates the course of Chlamydia pneumoniae infection [ J ]. Cell Microbiol, 2001, 3 (6) :427-437.
  • 7Belay T, Eko FO, Ananaba GA,et al. Chemokine and chemokine receptor dynamics during genital chlamydial infection [ J ]. Infect Immun, 2002,70 ( 2 ): 844-850.
  • 8Wood H, Fehlner-Gardner C, Berry J, et al. Regulation of tryptophan synthase gene expression in Chlamydia trachomatis[ J]. Mol Microbiol, 2003, 49 (5): 1347-1359.
  • 9Caspar-Bauguil S, Puissant B, Nazzal D, et al. Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class Ⅰ expression [ J ]. J Infect Dis,2000,182 (5): 1394-1401.
  • 10Zhong G, Fan T, Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class Ⅱ expression by degradation of upstream stimulatory factor 1 [ J ]. J Exp Med,1999, 189(12) :1931-1938.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部